Agios Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00847X1046

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Noubar Afeyan. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Noubar Afeyan telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:MRNA / Moderna, Inc. Director 2,224,015
US:SANA / Sana Biotechnology, Inc. 10% Owner 0
US:SGTX / Sigilon Therapeutics Inc 10% Owner 0
US:EVLO / Evelo Biosciences, Inc. 10% Owner 3,931,685
US:OMGA / Omega Therapeutics, Inc. Director, 10% Owner 1,329,324
US:AXLA / Axcella Health Inc. 10% Owner 3,048,780
US:CDAK / Codiak Biosciences Inc 10% Owner 1,188,920
US:MCRB / Seres Therapeutics, Inc. 10% Owner 5,825,495
US:RUBY / Rubius Therapeutics, Inc. Director, 10% Owner 25,000
US:KLDO / Kaleido Biosciences, Inc. 10% Owner 738,333
US:FHTX / Foghorn Therapeutics Inc. 10% Owner 0
US:TMDX / TransMedics Group, Inc. 10% Owner 0
US:SYRS / Syros Pharmaceuticals, Inc. 10% Owner 0
US:QTRX / Quanterix Corporation 10% Owner 0
US:DNLI / Denali Therapeutics Inc. 10% Owner 0
US:EBIO / Eleven Biotherapeutics, Inc. 10% Owner 106,787
US:EDIT / Editas Medicine, Inc. 10% Owner 0
US:SELB / Selecta Biosciences Inc 10% Owner 0
US:BGMD / BG Medicine, Inc. Director, 10% Owner 0
US:TTOO / T2 Biosystems, Inc. 10% Owner 0
US:AGIO / Agios Pharmaceuticals, Inc. 10% Owner 1,930,369
US:CNCE / Concert Pharmaceuticals Inc 10% Owner 0
US:RCPT / Receptos, Inc. 10% Owner 1,693,551
US:BIND / BIND Therapeutics, Inc. Director, 10% Owner 0
US:XLRN / Acceleron Pharma Inc 10% Owner 4,867
10% Owner 0
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Noubar Afeyan. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam AGIO / Agios Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Penjualan Orang Dalam AGIO / Agios Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Pembelian Orang Dalam BGMD / BG Medicine, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2013-01-30 BGMD AFEYAN NOUBAR 250,000 2.0000 62,500 8.0000 500,000 12 8.8 50,000 10.00
2013-01-30 BGMD AFEYAN NOUBAR 125,000 2.0000 31,250 8.0000 250,000
2013-01-30 BGMD AFEYAN NOUBAR 75,000 2.0000 18,750 8.0000 150,000
2013-01-30 BGMD AFEYAN NOUBAR 500,000 2.0000 125,000 8.0000 1,000,000
2013-01-30 BGMD AFEYAN NOUBAR 1,050,000 2.0000 262,500 8.0000 2,100,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

BGMD / BG Medicine, Inc. Insider Trades
Penjualan Orang Dalam BGMD / BG Medicine, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2015-12-09 BGMD AFEYAN NOUBAR 43,930 0.5600 43,930 0.5600 24,601 366 0.0474 -22,518 -91.54
2015-12-09 BGMD AFEYAN NOUBAR 2,508 0.5600 2,508 0.5600 1,404
2015-07-27 BGMD AFEYAN NOUBAR 206 2.2700 206 2.2700 468
2015-07-27 BGMD AFEYAN NOUBAR 16 2.2700 16 2.2700 36
2015-07-27 BGMD AFEYAN NOUBAR 16 2.2700 16 2.2700 36
2015-07-27 BGMD AFEYAN NOUBAR 16 2.2700 16 2.2700 36
2015-07-27 BGMD AFEYAN NOUBAR 16 2.2700 16 2.2700 36
2015-07-27 BGMD AFEYAN NOUBAR 32 2.2700 32 2.2700 73
2015-07-27 BGMD AFEYAN NOUBAR 3,390 2.2700 3,390 2.2700 7,695
2015-07-27 BGMD AFEYAN NOUBAR 265 2.2700 265 2.2700 602
2015-07-27 BGMD AFEYAN NOUBAR 265 2.2700 265 2.2700 602
2015-07-27 BGMD AFEYAN NOUBAR 265 2.2700 265 2.2700 602
2015-07-27 BGMD AFEYAN NOUBAR 265 2.2700 265 2.2700 602
2015-07-27 BGMD AFEYAN NOUBAR 530 2.2700 530 2.2700 1,203
2014-12-03 BGMD AFEYAN NOUBAR 616 0.4600 154 1.8400 283
2014-12-03 BGMD AFEYAN NOUBAR 616 0.4600 154 1.8400 283
2014-12-03 BGMD AFEYAN NOUBAR 616 0.4600 154 1.8400 283
2014-12-03 BGMD AFEYAN NOUBAR 39 0.4600 10 1.8400 18
2014-12-03 BGMD AFEYAN NOUBAR 32 0.4600 8 1.8400 15
2014-12-03 BGMD AFEYAN NOUBAR 63 0.4600 16 1.8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0.4600 16 1.8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0.4600 16 1.8400 29
2014-12-03 BGMD AFEYAN NOUBAR 37 0.4600 9 1.8400 17
2014-12-03 BGMD AFEYAN NOUBAR 31 0.4600 8 1.8400 14
2014-12-03 BGMD AFEYAN NOUBAR 63 0.4600 16 1.8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0.4600 16 1.8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0.4600 16 1.8400 29
2014-12-03 BGMD AFEYAN NOUBAR 927 0.4600 232 1.8400 426
2014-12-03 BGMD AFEYAN NOUBAR 216 0.4600 54 1.8400 99
2014-12-03 BGMD AFEYAN NOUBAR 440 0.4600 110 1.8400 202
2014-12-03 BGMD AFEYAN NOUBAR 440 0.4600 110 1.8400 202
2014-12-03 BGMD AFEYAN NOUBAR 440 0.4600 110 1.8400 202
2012-08-20 BGMD AFEYAN NOUBAR 13 5.8300 3 23.3200 76
2012-08-20 BGMD AFEYAN NOUBAR 23 5.8300 6 23.3200 134
2012-08-20 BGMD AFEYAN NOUBAR 23 5.8300 6 23.3200 134
2012-08-20 BGMD AFEYAN NOUBAR 23 5.8300 6 23.3200 134
2012-05-21 BGMD AFEYAN NOUBAR 19 3.9500 5 15.8000 75
2012-05-21 BGMD AFEYAN NOUBAR 14 3.9500 4 15.8000 55
2012-05-21 BGMD AFEYAN NOUBAR 36 3.9500 9 15.8000 142
2012-05-21 BGMD AFEYAN NOUBAR 36 3.9500 9 15.8000 142
2012-05-21 BGMD AFEYAN NOUBAR 36 3.9500 9 15.8000 142

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

BGMD / BG Medicine, Inc. Insider Trades
Pembelian Orang Dalam CARM / Carisma Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2014-02-11 EBIO Flagship Ventures Fund 2007, L.P. 214,095 10.0000 214,095 10.0000 2,140,950 730
2014-02-11 EBIO Flagship Ventures Fund 2007, L.P. 131,722 10.0000 131,722 10.0000 1,317,220
2014-02-11 EBIO Flagship Ventures Fund 2007, L.P. 32,912 10.0000 32,912 10.0000 329,120

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

CARM / Carisma Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam CARM / Carisma Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2016-09-23 EBIO Flagship Ventures Fund IV, L.P. 12,482 3.1600 12,482 3.1600 39,443 730
2016-09-23 EBIO Flagship Ventures Fund IV, L.P. 3,118 3.1600 3,118 3.1600 9,853
2016-09-23 EBIO Flagship Ventures Fund IV, L.P. 41,178 3.1000 41,178 3.1000 127,652
2016-09-23 EBIO Flagship Ventures Fund IV, L.P. 10,293 3.1000 10,293 3.1000 31,908
2016-09-22 EBIO Flagship Ventures Fund IV, L.P. 112,731 3.1800 112,731 3.1800 358,485
2016-09-22 EBIO Flagship Ventures Fund IV, L.P. 28,163 3.1800 28,163 3.1800 89,558
2016-09-22 EBIO Flagship Ventures Fund IV, L.P. 188,367 3.1700 188,367 3.1700 597,123
2016-09-22 EBIO Flagship Ventures Fund IV, L.P. 47,090 3.1700 47,090 3.1700 149,275
2016-09-21 EBIO Flagship Ventures Fund IV, L.P. 258,214 3.7500 258,214 3.7500 968,302
2016-09-21 EBIO Flagship Ventures Fund IV, L.P. 64,509 3.7500 64,509 3.7500 241,909
2016-09-20 EBIO Flagship Ventures Fund IV, L.P. 43,139 3.3900 43,139 3.3900 146,241
2016-09-20 EBIO Flagship Ventures Fund IV, L.P. 10,778 3.3900 10,778 3.3900 36,537
2016-09-19 EBIO Flagship Ventures Fund IV, L.P. 7,761 3.3100 7,761 3.3100 25,689
2016-09-19 EBIO Flagship Ventures Fund IV, L.P. 1,939 3.3100 1,939 3.3100 6,418
2016-09-15 EBIO Flagship Ventures Fund IV, L.P. 2,145 4.1600 2,145 4.1600 8,923
2016-09-15 EBIO Flagship Ventures Fund IV, L.P. 536 4.1600 536 4.1600 2,230
2016-09-14 EBIO Flagship Ventures Fund IV, L.P. 35,209 4.1800 35,209 4.1800 147,174
2016-09-14 EBIO Flagship Ventures Fund IV, L.P. 8,802 4.1800 8,802 4.1800 36,792
2016-09-07 EBIO Flagship Ventures Fund IV, L.P. 52,985 4.5100 52,985 4.5100 238,962
2016-09-07 EBIO Flagship Ventures Fund IV, L.P. 32,597 4.5100 32,597 4.5100 147,012
2016-09-07 EBIO Flagship Ventures Fund IV, L.P. 8,145 4.5100 8,145 4.5100 36,734
2016-09-06 EBIO Flagship Ventures Fund IV, L.P. 20,221 4.6300 20,221 4.6300 93,623
2016-09-06 EBIO Flagship Ventures Fund IV, L.P. 12,441 4.6300 12,441 4.6300 57,602
2016-09-06 EBIO Flagship Ventures Fund IV, L.P. 3,108 4.6300 3,108 4.6300 14,390

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

CARM / Carisma Therapeutics, Inc. Insider Trades
Pembelian Orang Dalam EDIT / Editas Medicine, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

EDIT / Editas Medicine, Inc. Insider Trades
Penjualan Orang Dalam EDIT / Editas Medicine, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

EDIT / Editas Medicine, Inc. Insider Trades
Pembelian Orang Dalam EVLO / Evelo Biosciences, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2023-07-11 EVLO Flagship Ventures Fund IV General Partner LLC 1,082,251 2.3100 1,082,251 2.3100 2,500,000 35 13.3100 11,904,762 476.19
2023-07-11 EVLO Flagship Ventures Fund IV General Partner LLC 1,082,251 2.3100 1,082,251 2.3100 2,500,000
2023-07-11 EVLO Flagship Ventures Fund IV General Partner LLC 3,246,753 2.3100 3,246,753 2.3100 7,499,999
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 4,383,561 1.4600 219,178 29.2000 6,399,999
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 1,095,890 1.4600 54,794 29.2000 1,599,999
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 1,369,863 1.4600 68,493 29.2000 2,000,000
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 6,849,315 1.4600 342,466 29.2000 10,000,000
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 13,698,630 1.4600 684,932 29.2000 20,000,000
2021-02-02 EVLO Flagship Ventures Fund IV General Partner LLC 37,143 15.0000 1,857 300.0000 557,145
2021-02-02 EVLO Flagship Ventures Fund IV General Partner LLC 9,285 15.0000 464 300.0000 139,275
2021-02-02 EVLO Flagship Ventures Fund IV General Partner LLC 37,143 15.0000 1,857 300.0000 557,145
2021-02-02 EVLO Flagship Ventures Fund IV General Partner LLC 46,429 15.0000 2,321 300.0000 696,435
2020-06-29 EVLO Flagship Ventures Fund IV General Partner LLC 1,333,333 3.7500 66,667 75.0000 4,999,999
2020-06-29 EVLO Flagship Ventures Fund IV General Partner LLC 333,333 3.7500 16,667 75.0000 1,249,999
2020-06-29 EVLO Flagship Ventures Fund IV General Partner LLC 1,333,333 3.7500 66,667 75.0000 4,999,999
2020-06-29 EVLO Flagship Ventures Fund IV General Partner LLC 1,666,667 3.7500 83,333 75.0000 6,250,001
2018-05-11 EVLO Flagship Ventures Fund V General Partner LLC 281,250 16.0000 14,062 320.0000 4,500,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

EVLO / Evelo Biosciences, Inc. Insider Trades
Penjualan Orang Dalam EVLO / Evelo Biosciences, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

EVLO / Evelo Biosciences, Inc. Insider Trades
Pembelian Orang Dalam FHTX / Foghorn Therapeutics Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2020-10-27 FHTX Flagship Ventures Fund V General Partner LLC 50,000 16.0000 50,000 16.0000 800,000 52 25.88 494,000 61.75
2020-10-27 FHTX Flagship Ventures Fund V General Partner LLC 50,000 16.0000 50,000 16.0000 800,000
2020-10-27 FHTX Flagship Ventures Fund V General Partner LLC 50,000 16.0000 50,000 16.0000 800,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

FHTX / Foghorn Therapeutics Inc. Insider Trades
Penjualan Orang Dalam FHTX / Foghorn Therapeutics Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

FHTX / Foghorn Therapeutics Inc. Insider Trades
Pembelian Orang Dalam KLDO / Kaleido Biosciences, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2021-02-08 KLDO Flagship Ventures Fund IV General Partner LLC 71,666 11.5000 71,666 11.5000 824,159 3 12.18 48,733 5.91
2021-02-08 KLDO Flagship Ventures Fund IV General Partner LLC 71,667 11.5000 71,667 11.5000 824,170
2021-02-08 KLDO Flagship Ventures Fund IV General Partner LLC 71,667 11.5000 71,667 11.5000 824,170
2020-06-04 KLDO Flagship Ventures Fund IV General Partner LLC 666,667 7.5000 666,667 7.5000 5,000,002
2020-06-04 KLDO Flagship Ventures Fund IV General Partner LLC 666,667 7.5000 666,667 7.5000 5,000,002
2020-06-04 KLDO Flagship Ventures Fund IV General Partner LLC 666,666 7.5000 666,666 7.5000 4,999,995
2019-03-04 KLDO Flagship Ventures Fund V General Partner LLC 266,667 15.0000 266,667 15.0000 4,000,005
2019-03-04 KLDO Flagship Ventures Fund V General Partner LLC 333,333 15.0000 333,333 15.0000 4,999,995
2019-03-04 KLDO Flagship Ventures Fund V General Partner LLC 333,333 15.0000 333,333 15.0000 4,999,995

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

KLDO / Kaleido Biosciences, Inc. Insider Trades
Penjualan Orang Dalam KLDO / Kaleido Biosciences, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

KLDO / Kaleido Biosciences, Inc. Insider Trades
Pembelian Orang Dalam MCRB / Seres Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2022-07-05 MCRB Nutritional Health LTP Fund General Partner LLC 2,912,748 3.1500 145,637 63.0000 9,175,156 119 9.0500 -7,857,141 -85.63
2022-07-05 MCRB Nutritional Health LTP Fund General Partner LLC 5,825,495 3.1500 291,275 63.0000 18,350,309
2019-06-18 MCRB AFEYAN NOUBAR 4,444,444 2.2500 222,222 45.0000 9,999,999
2019-06-18 MCRB AFEYAN NOUBAR 4,444,444 2.2500 222,222 45.0000 9,999,999

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

MCRB / Seres Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam MCRB / Seres Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2016-05-25 MCRB AFEYAN NOUBAR 320,562 27.6000 16,028 552.0000 8,847,511 203 8.9900 -8,703,419 -98.37
2016-05-25 MCRB AFEYAN NOUBAR 80,141 27.6000 4,007 552.0000 2,211,892
2016-05-25 MCRB AFEYAN NOUBAR 599,297 27.6000 29,965 552.0000 16,540,597

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

MCRB / Seres Therapeutics, Inc. Insider Trades
Pembelian Orang Dalam QTRX / Quanterix Corporation - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

QTRX / Quanterix Corporation Insider Trades
Penjualan Orang Dalam QTRX / Quanterix Corporation - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

QTRX / Quanterix Corporation Insider Trades
Pembelian Orang Dalam RNAC / Cartesian Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

RNAC / Cartesian Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam RNAC / Cartesian Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

RNAC / Cartesian Therapeutics, Inc. Insider Trades
Pembelian Orang Dalam SANA / Sana Biotechnology, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

SANA / Sana Biotechnology, Inc. Insider Trades
Penjualan Orang Dalam SANA / Sana Biotechnology, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2023-06-07 SANA Flagship Ventures Fund V General Partner LLC 177,240 6.2397 177,240 6.2397 1,105,924 142 2.8000 -609,652 -55.13
2023-06-07 SANA Flagship Ventures Fund V General Partner LLC 22,760 6.2397 22,760 6.2397 142,016
2023-06-06 SANA Flagship Ventures Fund V General Partner LLC 181,461 6.3061 181,461 6.3061 1,144,311
2023-06-06 SANA Flagship Ventures Fund V General Partner LLC 22,297 6.3061 22,297 6.3061 140,607
2023-05-26 SANA Flagship Ventures Fund V General Partner LLC 72,670 6.2265 72,670 6.2265 452,480
2023-05-26 SANA Flagship Ventures Fund V General Partner LLC 9,330 6.2265 9,330 6.2265 58,093
2023-05-25 SANA Flagship Ventures Fund V General Partner LLC 102,245 6.3522 102,245 6.3522 649,481
2023-05-25 SANA Flagship Ventures Fund V General Partner LLC 13,127 6.3522 13,127 6.3522 83,385
2023-05-24 SANA Flagship Ventures Fund V General Partner LLC 308,290 6.5652 308,290 6.5652 2,023,986
2023-05-24 SANA Flagship Ventures Fund V General Partner LLC 39,580 6.5652 39,580 6.5652 259,851

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

SANA / Sana Biotechnology, Inc. Insider Trades
Pembelian Orang Dalam SYRS / Syros Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2016-07-06 SYRS Flagship Ventures Fund IV, L.P. 320,000 12.5000 32,000 125.0000 4,000,000 348 185.7 1,942,400 48.56
2016-07-06 SYRS Flagship Ventures Fund IV, L.P. 80,000 12.5000 8,000 125.0000 1,000,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

SYRS / Syros Pharmaceuticals, Inc. Insider Trades
Penjualan Orang Dalam SYRS / Syros Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

SYRS / Syros Pharmaceuticals, Inc. Insider Trades
Pembelian Orang Dalam TMDX / TransMedics Group, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

TMDX / TransMedics Group, Inc. Insider Trades
Penjualan Orang Dalam TMDX / TransMedics Group, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di AGIO / Agios Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

TMDX / TransMedics Group, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Noubar Afeyan sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2024-08-02 2024-07-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,309 2,224,015 -0.06 121.62 -159,204 270,491,154
2024-08-02 2024-07-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,428 2,225,324 -0.15 120.88 -414,377 268,997,610
2024-08-02 2024-07-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,664 2,228,752 -0.25 119.84 -678,754 267,085,839
2024-08-02 2024-07-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,599 2,234,416 -0.21 118.96 -547,107 265,811,043
2024-07-26 2024-07-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,000 2,239,015 -0.09 119.01 -238,026 266,471,892
2024-07-26 2024-07-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,832 2,241,015 -0.30 118.30 -808,208 265,106,248
2024-07-26 2024-07-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,500 2,247,847 -0.16 117.25 -410,376 263,560,960
2024-07-26 2024-07-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,668 2,251,347 -0.12 116.33 -310,362 261,893,568
2024-07-19 2024-07-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 2,254,015 -0.03 124.61 -87,230 280,882,501
2024-07-19 2024-07-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,699 2,254,715 -0.30 123.82 -829,478 279,181,517
2024-07-19 2024-07-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,900 2,261,414 -0.13 122.86 -356,298 277,840,490
2024-07-19 2024-07-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,100 2,264,314 -0.09 121.57 -255,297 275,272,427
2024-07-19 2024-07-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,601 2,266,414 -0.11 120.86 -314,347 273,910,637
2024-07-12 2024-07-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -500 2,269,015 -0.02 119.95 -59,976 272,172,887
2024-07-12 2024-07-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,100 2,269,515 -0.05 119.28 -131,211 270,714,331
2024-07-12 2024-07-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,000 2,270,615 -0.13 117.83 -353,483 267,541,116
2024-07-12 2024-07-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,279 2,273,615 -0.19 117.18 -501,418 266,424,934
2024-07-12 2024-07-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,121 2,277,894 -0.27 116.01 -710,089 264,255,294
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 2,284,015 0.00 134.05 -13,405 306,172,211
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 2,284,115 -0.03 131.56 -92,089 300,488,348
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,705 2,284,815 -0.12 130.76 -353,695 298,753,270
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,300 2,287,520 -0.10 129.84 -298,631 297,010,911
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,435 2,289,820 -0.06 128.78 -184,798 294,880,501
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,100 2,291,255 -0.05 127.50 -140,254 292,143,032
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,100 2,292,355 -0.05 125.71 -138,277 288,163,695
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,500 2,293,455 -0.07 124.90 -187,352 286,455,970
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,600 2,294,955 -0.07 123.74 -197,978 283,969,240
2024-06-28 2024-06-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,460 2,296,555 -0.11 122.69 -301,814 281,761,347
2024-06-21 2024-06-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 2,299,015 0.00 136.92 -13,692 314,781,134
2024-06-21 2024-06-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 2,299,115 -0.01 135.02 -27,003 310,415,012
2024-06-21 2024-06-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,840 2,299,315 -0.30 134.09 -917,197 308,322,506
2024-06-21 2024-06-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,160 2,306,155 -0.27 133.26 -820,887 307,320,291
2024-06-21 2024-06-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,700 2,312,315 -0.07 132.22 -224,782 305,744,695
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 2,314,015 -0.01 150.24 -30,048 347,657,614
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,400 2,314,215 -0.06 149.39 -209,150 345,726,827
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,601 2,315,615 -0.07 148.61 -237,929 344,130,492
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,397 2,317,216 -0.28 147.55 -943,876 341,904,757
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,031 2,323,613 -0.13 146.55 -444,188 340,521,535
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,263 2,326,644 -0.05 145.57 -183,861 338,700,735
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -408 2,327,907 -0.02 144.46 -58,940 336,293,868
2024-06-14 2024-06-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 2,328,315 -0.03 142.97 -100,079 332,878,264
2024-06-11 2024-06-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale -1,232 1,528,557 -0.08 149.40 -184,065 228,372,224
2024-06-11 2024-06-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale -6,420 7,930,725 -0.08 149.40 -959,172 1,184,880,452
2024-06-11 2024-06-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale -31,531 1,529,789 -2.02 148.29 -4,675,871 226,859,142
2024-06-11 2024-06-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale -163,649 7,937,145 -2.02 148.29 -24,268,230 1,177,034,155
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,721 1,946,931 -0.09 154.86 -266,510 301,497,257
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -400 1,948,652 -0.02 153.71 -61,484 299,527,299
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,437 1,949,052 -0.12 152.90 -372,606 298,001,085
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,902 1,951,489 -0.20 151.76 -592,172 296,160,312
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,840 1,955,391 -0.15 151.07 -429,033 295,396,812
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 1,958,231 -0.02 149.35 -44,805 292,461,800
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,800 1,958,531 -0.09 148.57 -267,428 290,980,909
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 1,960,331 -0.04 147.78 -103,443 289,688,698
2024-06-07 2024-06-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -900 1,961,031 -0.05 145.91 -131,323 286,142,662
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,177 1,961,931 -0.16 148.06 -470,379 290,478,599
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,229 1,965,108 -0.11 146.82 -327,261 288,516,567
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,581 1,967,337 -0.28 146.02 -814,937 287,270,155
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,400 1,972,918 -0.12 144.99 -347,966 286,045,095
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,500 1,975,318 -0.08 143.94 -215,913 284,331,224
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,100 1,976,818 -0.06 142.82 -157,102 282,329,147
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,013 1,977,918 -0.15 141.72 -427,017 280,320,429
2024-05-31 2024-05-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,000 1,980,931 -0.05 141.01 -141,010 279,331,080
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -97 1,981,931 0.00 164.67 -15,973 326,364,578
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -625 1,982,028 -0.03 163.92 -102,451 324,896,408
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,223 1,982,653 -0.11 163.02 -362,401 323,219,230
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,005 1,984,876 -0.05 162.19 -163,003 321,930,611
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -825 1,985,881 -0.04 160.24 -132,194 318,208,635
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,200 1,986,706 -0.11 159.57 -351,050 317,015,299
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,923 1,988,906 -0.10 158.25 -304,320 314,750,142
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,802 1,990,829 -0.09 157.41 -283,656 313,379,777
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -600 1,992,631 -0.03 155.66 -93,396 310,172,941
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 1,993,231 -0.01 153.84 -30,768 306,638,657
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -800 1,993,431 -0.04 152.92 -122,336 304,835,469
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 1,994,231 -0.04 151.73 -106,213 302,590,453
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -400 1,994,931 -0.02 150.60 -60,238 300,426,634
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 1,995,331 -0.02 149.45 -44,836 298,208,803
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -600 1,995,631 -0.03 148.21 -88,924 295,765,885
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 1,996,231 -0.02 147.06 -44,119 293,572,318
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 1,996,531 -0.01 145.03 -14,503 289,556,891
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 1,996,631 -0.01 144.40 -28,879 288,303,533
2024-05-24 2024-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 1,996,831 -0.01 142.95 -14,295 285,446,991
2024-05-17 2024-05-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 1,996,931 -0.01 129.15 -25,830 257,903,639
2024-05-17 2024-05-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,711 1,997,131 -0.29 128.75 -735,272 257,123,826
2024-05-17 2024-05-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,600 2,002,842 -0.13 127.71 -332,036 255,775,541
2024-05-17 2024-05-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,001 2,005,442 -0.10 126.62 -253,368 253,930,670
2024-05-17 2024-05-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,488 2,007,443 -0.22 125.53 -563,357 251,984,483
2024-05-10 2024-05-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -7,996 2,011,931 -0.40 122.07 -976,063 245,594,204
2024-05-10 2024-05-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,004 2,019,927 -0.25 121.59 -608,416 245,594,844
2024-05-10 2024-05-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,000 2,024,931 -0.10 120.37 -240,741 243,741,957
2024-05-03 2024-05-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 2,026,931 -0.03 113.40 -79,379 229,851,138
2024-05-03 2024-05-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,500 2,027,631 -0.07 112.77 -169,151 228,650,473
2024-05-03 2024-05-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,246 2,029,131 -0.21 111.55 -473,650 226,353,621
2024-05-03 2024-05-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,572 2,033,377 -0.22 110.42 -504,860 224,534,232
2024-05-03 2024-05-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,982 2,037,949 -0.20 109.70 -436,815 223,557,707
2024-04-26 2024-04-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,100 2,041,931 -0.05 109.91 -120,901 224,428,636
2024-04-26 2024-04-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,153 2,043,031 -0.20 109.04 -452,847 222,774,143
2024-04-26 2024-04-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,821 2,047,184 -0.28 108.30 -630,388 221,700,815
2024-04-26 2024-04-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,926 2,053,005 -0.19 107.16 -420,700 219,994,473
2024-04-19 2024-04-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -282 2,056,931 -0.01 104.49 -29,466 214,927,897
2024-04-19 2024-04-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,475 2,057,213 -0.31 103.69 -671,398 213,314,062
2024-04-19 2024-04-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -8,243 2,063,688 -0.40 103.10 -849,839 212,762,725
2024-04-12 2024-04-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -389 2,071,931 -0.02 109.36 -42,542 226,592,176
2024-04-12 2024-04-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -748 2,072,320 -0.04 108.56 -81,205 224,977,483
2024-04-12 2024-04-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -7,512 2,073,068 -0.36 107.31 -806,136 222,467,354
2024-04-12 2024-04-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,351 2,080,580 -0.30 106.59 -676,982 221,778,385
2024-04-05 2024-04-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 2,086,931 0.00 104.15 -10,415 217,353,864
2024-04-05 2024-04-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,702 2,087,031 -0.13 103.64 -280,044 216,306,363
2024-04-05 2024-04-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,500 2,089,733 -0.17 102.64 -359,252 214,497,091
2024-04-05 2024-04-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,832 2,093,233 -0.18 101.33 -388,289 212,103,113
2024-04-05 2024-04-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,167 2,097,065 -0.15 100.66 -318,775 211,080,497
2024-04-05 2024-04-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,499 2,100,232 -0.07 99.40 -149,000 208,762,221
2024-04-05 2024-04-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 2,101,731 -0.01 97.47 -19,494 204,855,721
2024-03-29 2024-03-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,973 2,101,931 -0.14 110.75 -329,256 232,785,916
2024-03-29 2024-03-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,544 2,104,904 -0.22 110.24 -500,931 232,044,827
2024-03-29 2024-03-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,100 2,109,448 -0.15 109.09 -338,176 230,117,362
2024-03-29 2024-03-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,466 2,112,548 -0.07 107.79 -158,020 227,711,126
2024-03-29 2024-03-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,100 2,114,014 -0.05 106.71 -117,376 225,577,344
2024-03-29 2024-03-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,817 2,115,114 -0.09 105.73 -192,106 223,624,446
2024-03-22 2024-03-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,778 2,116,931 -0.27 103.18 -596,147 218,414,991
2024-03-22 2024-03-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -7,109 2,122,709 -0.33 102.15 -726,159 216,827,083
2024-03-22 2024-03-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,113 2,129,818 -0.10 101.05 -213,514 215,213,849
2024-03-15 2024-03-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 2,131,931 -0.01 112.44 -22,487 239,703,662
2024-03-15 2024-03-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,404 2,132,131 -0.07 111.69 -156,806 238,127,264
2024-03-15 2024-03-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,803 2,133,535 -0.18 110.80 -421,373 236,395,891
2024-03-15 2024-03-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -412 2,137,338 -0.02 109.50 -45,113 234,033,381
2024-03-15 2024-03-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -600 2,137,750 -0.03 108.52 -65,109 231,977,941
2024-03-15 2024-03-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,300 2,138,350 -0.11 107.66 -247,617 230,213,692
2024-03-15 2024-03-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,281 2,140,650 -0.29 106.60 -669,527 228,183,871
2023-11-03 2023-11-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -8,100 2,146,931 -0.38 76.17 -616,966 163,528,729
2023-11-03 2023-11-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,900 2,155,031 -0.09 75.30 -143,066 162,269,309
2023-10-27 2023-10-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -400 2,156,931 -0.02 78.42 -31,366 169,135,744
2023-10-27 2023-10-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,100 2,157,331 -0.14 77.34 -239,754 166,847,764
2023-10-27 2023-10-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,500 2,160,431 -0.30 76.73 -498,734 165,766,198
2023-10-13 2023-10-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 2,166,931 0.00 105.58 -10,558 228,784,575
2023-10-13 2023-10-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -500 2,167,031 -0.02 104.82 -52,408 227,139,521
2023-10-13 2023-10-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,700 2,167,531 -0.26 103.76 -591,421 224,898,681
2023-10-13 2023-10-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -8,700 2,173,231 -0.40 102.88 -895,054 223,581,571
2023-10-06 2023-10-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,866 2,181,931 -0.18 104.04 -402,206 227,001,119
2023-10-06 2023-10-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,604 2,185,797 -0.26 103.22 -578,445 225,618,185
2023-10-06 2023-10-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,700 2,191,401 -0.12 102.03 -275,486 223,592,369
2023-10-06 2023-10-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,800 2,194,101 -0.08 100.94 -181,690 221,470,141
2023-10-06 2023-10-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,030 2,195,901 -0.05 100.02 -103,018 219,628,748
2023-09-29 2023-09-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 2,196,931 -0.01 100.16 -20,033 220,055,594
2023-09-29 2023-09-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,596 2,197,131 -0.21 99.49 -457,245 218,587,510
2023-09-29 2023-09-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,204 2,201,727 -0.24 98.46 -512,367 216,774,114
2023-09-22 2023-09-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,006 2,206,931 -0.05 105.77 -106,404 233,424,885
2023-09-22 2023-09-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -9,380 2,207,937 -0.42 105.06 -985,422 231,956,146
2023-09-22 2023-09-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,614 2,217,317 -0.21 103.87 -479,265 230,316,930
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -70,813 0 -100.00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -2,431,281 7,293,841 -25.00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -1,181,745 0 -100.00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -345,069 1,035,208 -25.00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -4,926,378 8,057,470 -37.94
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -2,825,989 8,615,337 -24.70
2023-09-15 2023-09-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 2,221,931 0.00 114.32 -11,432 254,011,152
2023-09-15 2023-09-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -250 2,222,031 -0.01 113.22 -28,305 251,578,350
2023-09-15 2023-09-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -900 2,222,281 -0.04 112.17 -100,957 249,283,038
2023-09-15 2023-09-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,895 2,223,181 -0.17 111.23 -433,243 247,285,757
2023-09-15 2023-09-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,400 2,227,076 -0.06 110.26 -154,363 245,555,841
2023-09-15 2023-09-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,174 2,228,476 -0.19 108.77 -453,992 242,383,981
2023-09-15 2023-09-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,281 2,232,650 -0.19 108.21 -463,229 241,585,903
2023-09-08 2023-09-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 1,982,209 -0.02 108.91 -32,674 215,888,923
2023-09-08 2023-09-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,689 1,982,509 -0.29 108.07 -614,811 214,250,144
2023-09-08 2023-09-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -9,011 1,988,198 -0.45 107.27 -966,608 213,273,602
2023-09-01 2023-08-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -100 1,997,209 -0.01 117.21 -11,721 234,092,867
2023-09-01 2023-08-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,336 1,997,309 -0.22 116.57 -505,463 232,833,500
2023-09-01 2023-08-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,717 2,001,645 -0.24 115.43 -544,460 231,040,074
2023-09-01 2023-08-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,847 2,006,362 -0.29 114.64 -670,307 230,011,547
2023-08-25 2023-08-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 2,012,209 -0.01 116.46 -34,938 234,341,860
2023-08-25 2023-08-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -9,878 2,012,509 -0.49 115.84 -1,144,313 233,138,300
2023-08-25 2023-08-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,657 2,022,387 -0.18 115.16 -421,125 232,889,593
2023-08-25 2023-08-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -854 2,026,044 -0.04 113.83 -97,215 230,633,503
2023-08-25 2023-08-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -311 2,026,898 -0.02 112.61 -35,022 228,252,227
2023-08-18 2023-08-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 2,027,209 -0.01 99.50 -29,850 201,707,296
2023-08-18 2023-08-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,000 2,027,509 -0.20 98.82 -395,289 200,362,900
2023-08-18 2023-08-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,200 2,031,509 -0.06 98.07 -117,679 199,221,555
2023-08-18 2023-08-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,900 2,032,709 -0.14 96.44 -279,672 196,031,813
2023-08-18 2023-08-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,600 2,035,609 -0.08 95.70 -153,124 194,812,870
2023-08-15 2023-08-11 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
U - Other -113,960 0 -100.00 14.92 -1,700,283
2023-08-15 2023-08-11 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
U - Other -683,760 0 -100.00 14.92 -10,201,699
2023-08-04 2023-08-02 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -200 2,037,209 -0.01 113.68 -22,735 231,579,733
2023-08-04 2023-08-02 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -900 2,037,409 -0.04 112.59 -101,328 229,385,156
2023-08-04 2023-08-02 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,175 2,038,309 -0.20 111.46 -465,349 227,191,552
2023-08-04 2023-08-02 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -9,725 2,042,484 -0.47 110.59 -1,075,464 225,873,404
2023-07-28 2023-07-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,101 2,052,209 -0.05 121.29 -133,544 248,920,023
2023-07-28 2023-07-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -11,499 2,053,310 -0.56 120.50 -1,385,632 247,424,266
2023-07-28 2023-07-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,400 2,064,809 -0.12 119.61 -287,053 246,962,306
2023-07-21 2023-07-19 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,149 2,067,209 -0.25 126.08 -649,185 260,633,504
2023-07-21 2023-07-19 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -9,004 2,072,358 -0.43 125.26 -1,127,819 259,578,589
2023-07-21 2023-07-19 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -847 2,081,362 -0.04 124.14 -105,147 258,382,152
2023-07-14 2023-07-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 2,082,209 -0.01 127.15 -38,145 264,752,874
2023-07-14 2023-07-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,845 2,082,509 -0.33 126.27 -864,316 262,957,787
2023-07-14 2023-07-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,865 2,089,354 -0.28 125.61 -736,678 262,434,981
2023-07-14 2023-07-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,990 2,095,219 -0.09 124.59 -247,942 261,051,926
2023-07-13 2023-07-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 3,246,753 3,931,685 474.03 2.31 7,499,999 9,082,192
2023-07-13 2023-07-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1,082,251 1,493,241 263.33 2.31 2,500,000 3,449,387
2023-07-13 2023-07-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1,082,251 1,493,241 263.33 2.31 2,500,000 3,449,387
2023-07-07 2023-07-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -170 2,097,209 -0.01 128.17 -21,789 268,801,794
2023-07-07 2023-07-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,549 2,097,379 -0.07 127.55 -197,577 267,523,628
2023-07-07 2023-07-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,012 2,098,928 -0.05 126.54 -128,055 265,590,793
2023-07-07 2023-07-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,639 2,099,940 -0.13 125.14 -330,258 262,796,991
2023-07-07 2023-07-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,097 2,102,579 -0.29 124.17 -757,086 261,084,593
2023-07-07 2023-07-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,533 2,108,676 -0.17 123.46 -436,169 260,327,861
2023-06-30 2023-06-28 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,096 2,112,209 -0.10 122.82 -257,441 259,432,070
2023-06-30 2023-06-28 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -8,073 2,114,305 -0.38 121.87 -983,873 257,674,790
2023-06-30 2023-06-28 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,131 2,122,378 -0.15 120.77 -378,123 256,314,073
2023-06-30 2023-06-28 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,700 2,125,509 -0.08 119.84 -203,723 254,714,835
2023-06-23 2023-06-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -400 2,127,209 -0.02 123.48 -49,390 262,657,131
2023-06-23 2023-06-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,790 2,127,609 -0.32 122.26 -830,175 260,130,838
2023-06-23 2023-06-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -7,810 2,134,399 -0.36 121.60 -949,662 259,533,527
2023-06-16 2023-06-14 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -530 2,142,209 -0.02 128.15 -67,918 274,516,371
2023-06-16 2023-06-14 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,002 2,142,739 -0.14 127.19 -381,823 272,533,902
2023-06-16 2023-06-14 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,997 2,145,741 -0.28 126.17 -756,658 270,734,150
2023-06-16 2023-06-14 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,471 2,151,738 -0.25 125.43 -686,229 269,892,928
2023-06-09 2023-06-07 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,702 2,157,209 -0.13 126.59 -342,054 273,087,343
2023-06-09 2023-06-07 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -12,298 2,159,911 -0.57 125.76 -1,546,547 271,621,768
2023-06-08 2023-06-07 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -22,760 1,380,277 -1.62 6.24 -142,016 8,612,514
2023-06-08 2023-06-07 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -177,240 10,743,293 -1.62 6.24 -1,105,924 67,034,925
2023-06-08 2023-06-06 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -22,297 1,403,037 -1.56 6.31 -140,607 8,847,692
2023-06-08 2023-06-06 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -181,461 10,920,533 -1.63 6.31 -1,144,311 68,865,973
2023-06-02 2023-05-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -600 2,172,209 -0.03 129.68 -77,807 281,688,370
2023-06-02 2023-05-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,441 2,172,809 -0.11 128.55 -313,780 279,305,037
2023-06-02 2023-05-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -5,637 2,175,250 -0.26 127.84 -720,629 278,082,002
2023-06-02 2023-05-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,373 2,180,887 -0.15 126.72 -427,440 276,370,942
2023-06-02 2023-05-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,949 2,184,260 -0.13 125.69 -370,666 274,544,226
2023-05-26 2023-05-26 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -9,330 1,425,334 -0.65 6.23 -58,093 8,874,842
2023-05-26 2023-05-26 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -72,670 11,101,994 -0.65 6.23 -452,480 69,126,566
2023-05-26 2023-05-25 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -13,127 1,434,664 -0.91 6.35 -83,385 9,113,273
2023-05-26 2023-05-25 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -102,245 11,174,664 -0.91 6.35 -649,481 70,983,701
2023-05-26 2023-05-24 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -39,580 1,447,791 -2.66 6.57 -259,851 9,505,037
2023-05-26 2023-05-24 4 SANA Sana Biotechnology, Inc.
Common Stock
S - Sale -308,290 11,276,909 -2.66 6.57 -2,023,986 74,035,163
2023-03-03 2023-03-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,187,209 -0.46 139.00 -1,390,000 304,022,051
2023-02-27 2023-02-27 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 1,329,324 1,329,324 5.78 7,683,493 7,683,493
2023-02-27 2023-02-27 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 1,993,986 7,508,693 36.16 5.78 11,525,239 43,400,246
2023-02-24 2023-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,197,209 -0.45 160.35 -1,603,500 352,322,463
2023-02-17 2023-02-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,207,209 -0.45 173.17 -1,731,700 382,222,383
2023-02-10 2023-02-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -11,000 2,217,209 -0.49 169.32 -1,862,516 375,416,941
2023-02-10 2023-02-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,100 2,228,209 -0.09 168.27 -353,364 374,937,609
2023-02-10 2023-02-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -300 2,230,309 -0.01 166.59 -49,977 371,547,176
2023-02-10 2023-02-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -3,700 2,230,609 -0.17 165.83 -613,577 369,905,459
2023-02-10 2023-02-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -2,900 2,234,309 -0.13 164.60 -477,327 367,757,430
2023-01-27 2023-01-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,237,209 -0.44 194.33 -1,943,300 434,756,825
2023-01-20 2023-01-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,247,209 -0.44 200.20 -2,002,000 449,891,242
2023-01-13 2023-01-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,257,209 -0.44 188.57 -1,885,700 425,641,901
2023-01-06 2023-01-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,267,209 -0.44 182.15 -1,821,500 412,972,119
2022-12-23 2022-12-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,277,209 -0.44 201.70 -2,017,000 459,313,055
2022-12-16 2022-12-14 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,287,209 -0.44 195.00 -1,950,000 446,005,755
2022-12-09 2022-12-07 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,297,209 -0.43 172.16 -1,721,600 395,487,501
2022-12-02 2022-11-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,307,209 -0.43 173.52 -1,735,200 400,346,906
2022-11-25 2022-11-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,317,209 -0.43 178.01 -1,780,100 412,486,374
2022-11-18 2022-11-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,327,209 -0.43 184.25 -1,842,500 428,788,258
2022-11-10 2022-11-09 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,337,209 -0.43 162.50 -1,625,000 379,796,462
2022-11-04 2022-11-02 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,347,209 -0.42 154.20 -1,542,000 361,939,628
2022-10-28 2022-10-26 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,357,209 -0.42 137.25 -1,372,500 323,526,935
2022-10-21 2022-10-19 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,367,209 -0.42 132.50 -1,325,000 313,655,192
2022-10-17 2022-10-13 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 3,048,780 3,048,780 1.64 4,999,999 4,999,999
2022-10-17 2022-10-13 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 919,111 6,299,611 17.08 1.64 1,507,342 10,331,362
2022-10-17 2022-10-13 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 914,634 5,380,500 20.48 1.64 1,500,000 8,824,020
2022-10-17 2022-10-13 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 2,757,333 14,101,638 24.31 1.64 4,522,026 23,126,686
2022-10-17 2022-10-13 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 2,743,902 11,344,305 31.90 1.64 4,499,999 18,604,660
2022-10-14 2022-10-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,377,209 -0.42 135.36 -1,353,600 321,779,010
2022-10-07 2022-10-05 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,387,209 -0.42 122.40 -1,224,000 292,194,382
2022-09-30 2022-09-28 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,397,209 -0.42 123.58 -1,235,800 296,247,088
2022-09-23 2022-09-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,407,209 -0.41 130.37 -1,303,700 313,827,837
2022-09-16 2022-09-14 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,417,209 -0.41 134.00 -1,340,000 323,906,006
2022-09-16 2022-09-15 4 CDAK Codiak BioSciences, Inc.
Common Stock
P - Purchase 210,743 1,188,920 21.54
2022-09-16 2022-09-15 4 CDAK Codiak BioSciences, Inc.
Common Stock
P - Purchase 722,590 1,865,767 63.21
2022-09-09 2022-09-07 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,427,209 -0.41 129.68 -1,296,800 314,760,463
2022-09-02 2022-08-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,437,209 -0.41 136.95 -1,369,500 333,775,773
2022-08-19 2022-08-17 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,447,209 -0.41 165.24 -1,652,400 404,376,815
2022-08-12 2022-08-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,457,209 -0.41 174.09 -1,740,900 427,775,515
2022-08-05 2022-08-03 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,467,209 -0.40 167.99 -1,679,900 414,466,440
2022-07-29 2022-07-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,477,209 -0.40 161.00 -1,610,000 398,830,649
2022-07-22 2022-07-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,487,209 -0.40 167.00 -1,670,000 415,363,903
2022-07-15 2022-07-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,497,209 -0.40 168.88 -1,688,800 421,728,656
2022-07-15 2022-07-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,497,209 -0.40 168.88 -1,688,800 421,728,656
2022-07-08 2022-07-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,507,209 -0.40 154.85 -1,548,500 388,241,314
2022-07-07 2022-07-05 4 MCRB Seres Therapeutics, Inc.
Common Stock
P - Purchase 5,825,495 5,825,495 3.15 18,350,309 18,350,309
2022-07-07 2022-07-05 4 MCRB Seres Therapeutics, Inc.
Common Stock
P - Purchase 2,912,748 5,875,711 98.31 3.15 9,175,156 18,508,490
2022-07-01 2022-06-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,517,209 -0.40 140.47 -1,404,700 353,592,348
2022-06-24 2022-06-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,527,209 -0.39 127.69 -1,276,900 322,699,317
2022-06-10 2022-06-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,537,209 -0.39 147.47 -1,474,700 374,162,211
2022-06-03 2022-06-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,547,209 -0.39 146.31 -1,463,100 372,682,149
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 13,698,630 13,698,630 1.46 20,000,000 20,000,000
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 6,849,315 8,219,791 499.78 1.46 10,000,000 12,000,895
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1,369,863 5,495,324 33.21 1.46 2,000,000 8,023,173
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1,095,890 1,887,419 138.45 1.46 1,599,999 2,755,632
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 4,383,561 7,590,873 136.67 1.46 6,399,999 11,082,675
2022-05-27 2022-05-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,557,209 -0.39 130.80 -1,308,000 334,482,937
2022-05-20 2022-05-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,567,209 -0.39 138.38 -1,383,800 355,250,381
2022-05-13 2022-05-12 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2022-05-13 2022-05-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale -100 5,816,657 0.00 136.00 -13,600 791,065,352
2022-05-13 2022-05-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale -49,900 5,816,757 -0.85 135.36 -6,754,714 787,385,311
2022-05-13 2022-05-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale -24,567 5,866,657 -0.42 134.04 -3,293,015 786,379,611
2022-05-13 2022-05-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale -25,433 5,891,224 -0.43 133.11 -3,385,282 784,156,673
2022-05-13 2022-05-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale -31,618 5,916,657 -0.53 132.22 -4,180,674 782,327,013
2022-05-13 2022-05-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale -51,256 5,948,275 -0.85 131.45 -6,737,478 781,886,473
2022-05-13 2022-05-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale -41,182 5,999,531 -0.68 130.08 -5,356,765 780,391,395
2022-05-13 2022-05-12 4 MRNA Moderna, Inc.
Common Stock
S - Sale -75,944 6,040,713 -1.24 129.39 -9,826,257 781,596,982
2022-05-13 2022-05-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -10,000 2,229,673 -0.45 130.74 -1,307,400 291,507,448
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Restricted Stock Units
M - Exercise -703 0 -100.00
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 5,415 5,415
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Common Stock
M - Exercise 703 2,239,673 0.03
2022-03-18 2022-03-16 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1,579,843 4,465,866 54.74 1.91 3,017,500 8,529,804
2022-03-18 2022-03-16 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 947,905 2,004,657 89.70 1.91 1,810,499 3,828,895
2022-03-18 2022-03-16 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 3,791,623 8,600,403 78.85 1.91 7,242,000 16,426,770
2022-02-14 2021-08-11 5 MRNA Moderna, Inc.
Common Stock
G - Gift -100,000 2,238,970 -4.28
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -1,666,666 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -5,000,000 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -1,666,667 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -3,333,333 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -13,333,333 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -666,667 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -2,666,667 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -3,000,000 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -27,388,000 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -22,275,232 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -4,112,000 0 -100.00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 294,117 1,617,646 22.22 17.00 4,999,989 27,499,982
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 1,323,529 1,323,529
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 661,764 5,514,707 13.64 17.00 11,249,988 93,750,019
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 4,852,943 4,852,943
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 970,588 970,588
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 220,588 8,617,413 2.63 17.00 3,749,996 146,496,021
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 8,396,825 8,396,825
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 5,896,386 5,896,386
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 1,088,470 1,088,470
2021-07-30 2021-07-29 4 OMGA Omega Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 19,852 19,852
2021-07-29 3 OMGA Omega Therapeutics, Inc.
Common Stock
2,197,059
2021-05-19 2021-05-17 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -295,171 2,962,963 -9.06
2021-05-13 2021-05-12 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2021-04-30 2021-04-28 4 MRNA Moderna, Inc.
Restricted Stock Units
A - Award 703 703
2021-04-30 2021-04-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 4,081 4,081
2021-03-31 2021-03-31 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -4,888 9,116,657 -0.05 121.07 -591,810 1,103,790,130
2021-03-31 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,000 9,121,545 -0.01 123.44 -123,440 1,125,963,515
2021-03-31 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -31,943 9,122,545 -0.35 123.08 -3,931,538 1,122,801,014
2021-03-31 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -14,379 9,154,488 -0.16 121.71 -1,750,038 1,114,173,510
2021-03-31 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -225,732 9,168,867 -2.40 120.76 -27,259,283 1,107,227,794
2021-03-31 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -344,542 9,394,599 -3.54 119.81 -41,278,061 1,125,525,570
2021-03-31 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -611,922 9,739,141 -5.91 118.90 -72,758,505 1,157,999,448
2021-03-31 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -883,277 10,351,063 -7.86 118.04 -104,265,815 1,221,883,986
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -558 11,234,340 0.00 131.30 -73,265 1,475,068,842
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,610 11,234,898 -0.06 130.56 -862,994 1,466,814,801
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -83,242 11,241,508 -0.74 129.54 -10,783,377 1,456,253,050
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -123,374 11,324,750 -1.08 128.74 -15,883,527 1,457,981,157
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -46,872 11,448,124 -0.41 127.47 -5,974,788 1,459,295,801
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -82,557 11,494,996 -0.71 126.40 -10,434,924 1,452,928,411
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -116,383 11,577,553 -1.00 125.36 -14,589,226 1,451,307,630
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -251,545 11,693,936 -2.11 124.42 -31,296,927 1,454,945,484
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -639,681 11,945,481 -5.08 123.50 -78,998,365 1,475,225,094
2021-03-31 2021-03-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -284,300 12,585,162 -2.21 122.53 -34,836,672 1,542,121,567
2021-03-23 2021-03-19 4 RUBY Rubius Therapeutics, Inc.
Common Stock
P - Purchase 70,000 2,633,703 2.73 29.00 2,030,000 76,377,387
2021-03-23 2021-03-19 4 RUBY Rubius Therapeutics, Inc.
Common Stock
P - Purchase 70,000 2,633,703 2.73 29.00 2,030,000 76,377,387
2021-03-23 2021-03-19 4 RUBY Rubius Therapeutics, Inc.
Common Stock
P - Purchase 70,000 15,393,593 0.46 29.00 2,030,000 446,414,197
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -23,423 14,623,159 -0.16 151.29 -3,543,551 2,212,266,072
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -190,710 14,646,582 -1.29 150.51 -28,704,468 2,204,511,249
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -179,268 14,837,292 -1.19 149.63 -26,823,154 2,220,044,653
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -268,688 15,016,560 -1.76 148.52 -39,905,810 2,230,274,508
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -292,483 15,285,248 -1.88 147.57 -43,162,565 2,255,688,375
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -307,795 15,577,731 -1.94 146.64 -45,134,105 2,284,270,183
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -357,316 15,885,526 -2.20 145.48 -51,982,439 2,311,031,088
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -405,551 16,242,842 -2.44 144.55 -58,623,573 2,347,949,915
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -397,126 16,648,393 -2.33 143.57 -57,017,127 2,390,283,036
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -117,011 17,045,519 -0.68 142.76 -16,704,549 2,433,426,815
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -70,631 17,162,530 -0.41 141.46 -9,991,271 2,427,765,155
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -102,852 17,233,161 -0.59 140.24 -14,423,553 2,416,709,566
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -56,435 17,336,013 -0.32 139.64 -7,880,849 2,420,882,335
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -46,222 17,392,448 -0.27 138.56 -6,404,451 2,409,871,506
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -122,142 17,438,670 -0.70 137.29 -16,768,948 2,394,165,468
2021-02-24 2021-02-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -9,985 17,560,812 -0.06 136.48 -1,362,773 2,396,734,743
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -30,968 17,570,797 -0.18 170.03 -5,265,421 2,987,523,958
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -54,274 17,601,735 -0.31 169.14 -9,179,910 2,977,159,218
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -58,377 17,656,009 -0.33 168.11 -9,813,857 2,968,181,688
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -122,715 17,714,386 -0.69 167.10 -20,505,750 2,960,084,529
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -351,578 17,837,101 -1.93 166.30 -58,466,296 2,966,252,818
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -165,578 18,188,311 -0.90 165.47 -27,397,976 3,009,596,176
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -189,200 18,353,889 -1.02 164.13 -31,054,266 3,012,508,229
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -366,471 18,543,089 -1.94 163.25 -59,827,380 3,027,209,346
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -250,501 18,909,560 -1.31 162.36 -40,672,044 3,070,209,108
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -30,808 19,160,061 -0.16 160.96 -4,958,809 3,083,974,678
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -54,409 19,190,869 -0.28 160.37 -8,725,620 3,077,656,933
2021-02-24 2021-02-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -161,887 19,245,278 -0.83 159.18 -25,769,076 3,063,451,805
2021-02-24 2021-02-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -35,000 12,869,462 -0.27 150.41 -5,264,350 1,935,695,779
2021-02-24 2021-02-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -99,005 12,904,462 -0.76 148.91 -14,742,765 1,921,594,403
2021-02-24 2021-02-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -267,038 13,003,467 -2.01 148.01 -39,523,921 1,924,624,946
2021-02-24 2021-02-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -288,656 13,270,505 -2.13 147.17 -42,481,157 1,953,004,296
2021-02-24 2021-02-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -351,112 13,559,161 -2.52 146.05 -51,281,277 1,980,368,345
2021-02-24 2021-02-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -354,358 13,910,273 -2.48 145.04 -51,396,616 2,017,566,861
2021-02-24 2021-02-24 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -358,528 14,264,631 -2.45 144.17 -51,688,838 2,056,526,145
2021-02-10 2021-02-08 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 71,667 738,333 10.75 11.50 824,170 8,490,830
2021-02-10 2021-02-08 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 71,667 738,333 10.75 11.50 824,170 8,490,830
2021-02-10 2021-02-08 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 71,666 1,685,444 4.44 11.50 824,159 19,382,606
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -11,585,199 0 -100.00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -11,441,326 0 -100.00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -9,725,122 0 -100.00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -1,487,371 0 -100.00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 11,585,199 11,585,199
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 11,441,326 11,441,326
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 9,725,122 9,725,122
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 1,487,371 1,487,371
2021-02-04 2021-02-02 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 46,429 4,125,461 1.14 15.00 696,435 61,881,915
2021-02-04 2021-02-02 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 37,143 1,370,476 2.79 15.00 557,145 20,557,140
2021-02-04 2021-02-02 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 37,143 1,370,476 2.79 15.00 557,145 20,557,140
2021-02-04 2021-02-02 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 9,285 791,529 1.19 15.00 139,275 11,872,935
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -1,481,481 0 -100.00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -370,370 0 -100.00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -4,074,074 0 -100.00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -4,444,444 0 -100.00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
C - Conversion 1,481,481 1,481,481
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
C - Conversion 8,888,888 8,888,888
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -43,154 0 -100.00
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -1,481,481 2,962,963 -33.33
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -1,186,310 3,258,134 -26.69
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -966,234 0 -100.00
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -642,180 1,283,282 -33.35
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -3,587,820 4,434,600 -44.72
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series B Convertible Preferred Stock
C - Conversion -3,333,333 0 -100.00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series B Convertible Preferred Stock
C - Conversion -2,666,666 0 -100.00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series B Convertible Preferred Stock
C - Conversion -1,336,293 0 -100.00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -8,333,333 0 -100.00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -7,500,000 0 -100.00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
P - Purchase 50,000 1,851,801 2.78 16.00 800,000 29,628,816
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
P - Purchase 50,000 1,851,801 2.78 16.00 800,000 29,628,816
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 1,801,801 1,801,801
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
P - Purchase 50,000 1,491,441 3.47 16.00 800,000 23,863,056
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 1,441,441 1,441,441
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 722,320 9,280,878 8.44
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 4,504,504 8,558,558 111.11
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 4,054,054 4,054,054
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Series C Preferred Stock
C - Conversion -660,048 0 -100.00
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Series C Preferred Stock
C - Conversion -660,048 0 -100.00
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Series B Preferred Stock
C - Conversion -2,416,666 0 -100.00
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Series B Preferred Stock
C - Conversion -2,416,666 0 -100.00
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Series A Preferred Stock
C - Conversion -4,250,000 0 -100.00
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Series A Preferred Stock
C - Conversion -4,250,000 0 -100.00
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Common Stock
P - Purchase 165,000 1,143,177 16.87 15.00 2,475,000 17,147,655
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Common Stock
C - Conversion 95,861 978,177 10.86
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Common Stock
C - Conversion 95,861 978,177 10.86
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Common Stock
C - Conversion 338,630 882,316 62.28
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Common Stock
C - Conversion 338,630 882,316 62.28
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Common Stock
C - Conversion 543,686 543,686
2020-10-20 2020-10-16 4 CDAK Codiak BioSciences, Inc.
Common Stock
C - Conversion 543,686 543,686
2020-10-13 3 CDAK Codiak BioSciences, Inc.
Common Stock
485,949
2020-08-19 2020-08-17 4 MRNA Moderna, Inc.
Common Stock
J - Other -2,053,049 0 -100.00
2020-08-19 2020-08-17 4 MRNA Moderna, Inc.
Common Stock
J - Other -1,449,190 4,971,576 -22.57
2020-08-19 2020-08-17 4 MRNA Moderna, Inc.
Common Stock
J - Other -7,550,810 14,435,589 -34.34
2020-07-01 2020-06-29 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1,666,667 4,079,032 69.09 3.75 6,250,001 15,296,370
2020-07-01 2020-06-29 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1,333,333 1,333,333 3.75 4,999,999 4,999,999
2020-07-01 2020-06-29 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1,333,333 1,333,333 3.75 4,999,999 4,999,999
2020-07-01 2020-06-29 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 333,333 782,244 74.25 3.75 1,249,999 2,933,415
2020-06-08 2020-06-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 666,666 666,666 7.50 4,999,995 4,999,995
2020-06-08 2020-06-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 666,667 2,910,972 29.70 7.50 5,000,002 21,832,290
2020-06-08 2020-06-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 666,667 2,910,972 29.70 7.50 5,000,002 21,832,290
2020-05-26 2020-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale -10,746 6,420,766 -0.17 70.18 -754,113 450,584,959
2020-05-26 2020-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale -69,254 6,431,512 -1.07 69.45 -4,809,448 446,645,998
2020-05-26 2020-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale -56,406 21,986,399 -0.26 70.18 -3,958,353 1,542,919,735
2020-05-26 2020-05-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale -363,594 22,042,805 -1.62 69.45 -25,250,331 1,530,795,657
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -367 6,500,766 -0.01 72.44 -26,584 470,886,236
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -2,551 6,501,133 -0.04 71.51 -182,433 464,924,626
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -3,900 6,503,684 -0.06 70.46 -274,780 458,226,161
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -7,443 6,507,584 -0.11 68.81 -512,185 447,814,838
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -23,199 6,515,027 -0.35 67.15 -1,557,822 437,486,669
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -42,540 6,538,226 -0.65 65.77 -2,797,690 429,993,625
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -1,933 22,406,399 -0.01 72.44 -140,017 1,623,009,752
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -13,408 22,408,332 -0.06 71.51 -958,861 1,602,511,695
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -20,492 22,421,740 -0.09 70.46 -1,443,793 1,579,755,082
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -39,082 22,442,232 -0.17 68.81 -2,689,404 1,544,348,730
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -121,771 22,481,314 -0.54 67.15 -8,176,971 1,509,629,228
2020-05-26 2020-05-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale -223,314 22,603,085 -0.98 65.77 -14,686,491 1,486,516,748
2020-05-26 2020-05-21 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2020-05-20 2020-05-18 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1,900,000 2,886,023 192.69 4.75 9,025,000 13,708,609
2020-05-20 2020-05-18 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 380,000 1,056,752 56.15 4.75 1,805,000 5,019,572
2020-05-20 2020-05-18 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 1,520,000 4,808,780 46.22 4.75 7,220,000 22,841,705
2020-05-13 2020-05-11 4 MRNA Moderna, Inc.
Common Stock
J - Other -2,281,179 0 -100.00
2020-05-13 2020-05-11 4 MRNA Moderna, Inc.
Common Stock
J - Other -1,610,000 6,580,766 -19.66
2020-05-13 2020-05-11 4 MRNA Moderna, Inc.
Common Stock
J - Other -8,390,000 22,826,399 -26.88
2020-04-30 2020-04-29 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 18,270 18,270
2019-12-11 2019-12-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale -38,366 8,190,766 -0.47 18.65 -715,710 152,797,102
2019-12-11 2019-12-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale -199,935 31,216,399 -0.64 18.65 -3,729,747 582,335,680
2019-12-11 2019-12-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale -4,092 8,229,132 -0.05 18.96 -77,579 156,012,822
2019-12-11 2019-12-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale -21,325 31,416,334 -0.07 18.96 -404,292 595,609,710
2019-12-11 2019-12-09 4 MRNA Moderna, Inc.
Common Stock
S - Sale -27,714 8,233,224 -0.34 18.99 -526,408 156,384,327
2019-12-11 2019-12-09 4 MRNA Moderna, Inc.
Common Stock
S - Sale -144,423 31,437,659 -0.46 18.99 -2,743,199 597,133,183
2019-12-11 2019-12-09 4 MRNA Moderna, Inc.
Common Stock
J - Other -1,735,720 0 -100.00
2019-12-11 2019-12-09 4 MRNA Moderna, Inc.
Common Stock
J - Other -1,207,658 8,260,938 -12.75
2019-12-11 2019-12-09 4 MRNA Moderna, Inc.
Common Stock
J - Other -6,292,342 31,582,082 -16.61
2019-10-31 2019-10-29 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other -248,379 0 -100.00
2019-10-31 2019-10-29 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other -61,537 0 -100.00
2019-10-31 2019-10-29 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other -1,061,102 0 -100.00
2019-10-31 2019-10-29 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other -1,469,173 0 -100.00
2019-06-28 2019-06-27 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 54,660 54,660
2019-06-20 2019-06-18 4 MCRB Seres Therapeutics, Inc.
Common Stock
P - Purchase 4,444,444 4,444,444 2.25 9,999,999 9,999,999
2019-06-20 2019-06-18 4 MCRB Seres Therapeutics, Inc.
Common Stock
P - Purchase 4,444,444 4,444,444 2.25 9,999,999 9,999,999
2019-06-14 2019-06-13 4 MCRB Seres Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2019-06-13 2019-06-12 4 EVLO Evelo Biosciences, Inc.
Stock Option (Right to Buy)
A - Award 15,690 15,690
2019-05-28 2019-05-23 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series E Preferred Stock
C - Conversion -895,255 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series E Preferred Stock
C - Conversion -89,525 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series E Preferred Stock
C - Conversion -358,102 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series C Preferred Stock
C - Conversion -151,643 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series C Preferred Stock
C - Conversion -617,914 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series C Preferred Stock
C - Conversion -222,506 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series B Preferred Stock
C - Conversion -1,005,413 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series B Preferred Stock
C - Conversion -928,074 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series B Preferred Stock
C - Conversion -386,697 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series A Preferred Stock
C - Conversion -4,153,847 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Series A Preferred Stock
C - Conversion -1,384,615 0 -100.00
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
P - Purchase 500,000 986,023 102.88 20.00 10,000,000 19,720,460
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 486,023 486,023
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 48,602 676,752 7.74
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 194,409 3,288,780 6.28
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 82,324 628,150 15.08
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 335,457 3,094,371 12.16
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 120,795 1,761,029 7.36
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 545,826 545,826
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 503,840 2,758,914 22.34
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 209,933 1,640,234 14.68
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 2,255,074 2,255,074
2019-05-15 2019-05-13 4 AXLA Axcella Health Inc.
Common Stock
C - Conversion 751,691 1,430,301 110.77
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
3,393,050
2019-05-08 3 AXLA Axcella Health Inc.
Common Stock
4,750,270
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Series B-1 Convertible Preferred Stock
C - Conversion -1,682,665 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Series F Convertible Preferred Stock
C - Conversion -450,958 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Series D Convertible Preferred Stock
C - Conversion -600,000 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Series C Convertible Preferred Stock
C - Conversion -1,257,465 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Series F Convertible Preferred Stock
C - Conversion -992,110 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Series D Convertible Preferred Stock
C - Conversion -1,400,000 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Series C Convertible Preferred Stock
C - Conversion -2,000,000 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Common Stock
C - Conversion 792,366 1,061,102 294.85
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Common Stock
C - Conversion 1,254,888 1,469,173 585.62
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other 268,736 268,736
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other -940,579 0 -100.00
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other 214,285 214,285
2019-05-06 2019-05-06 4 TMDX TransMedics Group, Inc.
Common Stock
J - Other -750,000 0 -100.00
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
697,306
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
751,757
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
697,306
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
751,757
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
697,306
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
751,757
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
697,306
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
751,757
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
697,306
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
751,757
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
697,306
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
751,757
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
697,306
2019-05-01 3 TMDX TransMedics Group, Inc.
Common Stock
751,757
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series C Preferred Stock
C - Conversion -1,251,251 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series C Preferred Stock
C - Conversion -1,251,251 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series B Preferred Stock
C - Conversion -2,570,694 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series B Preferred Stock
C - Conversion -1,928,021 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series B Preferred Stock
C - Conversion -642,674 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A-1 Preferred Stock
C - Conversion -1,278,720 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A-1 Preferred Stock
C - Conversion -852,480 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A Preferred Stock
C - Conversion -9,275,111 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A Preferred Stock
C - Conversion -3,091,704 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 333,333 2,244,305 17.44 15.00 4,999,995 33,664,575
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 333,333 2,244,305 17.44 15.00 4,999,995 33,664,575
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 266,667 2,560,096 11.63 15.00 4,000,005 38,401,440
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 625,625 1,910,972 48.67
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 625,625 1,910,972 48.67
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 1,285,347 1,285,347
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 964,010 5,601,565 20.79
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 321,337 2,293,429 16.29
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 639,360 639,360
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 426,240 1,972,092 27.57
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 4,637,555 4,637,555
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 1,545,852 1,545,852
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A-1 Preferred Stock
C - Conversion -562,407 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A-1 Preferred Stock
C - Conversion -347,173 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A Preferred Stock
C - Conversion -1,331,816 0 -100.00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 281,203 947,111 42.23
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 173,586 216,451 404.96
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 665,908 665,908
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
1,778,594
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
3,385,728
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5,000,000
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series D Preferred Stock
C - Conversion -21,496 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series D Preferred Stock
C - Conversion -85,989 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series C Preferred Stock
C - Conversion -1,428,432 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series C Preferred Stock
C - Conversion -5,713,739 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series B Preferred Stock
C - Conversion -6,195,632 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series B Preferred Stock
C - Conversion -24,782,551 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series A Preferred Stock
C - Conversion -1,823,036 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series A Preferred Stock
C - Conversion -7,292,145 0 -100.00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 21,496 9,468,596 0.23
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 85,989 37,874,424 0.23
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 1,428,432 9,447,100 17.81
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 5,713,739 37,788,435 17.81
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 6,195,632 8,018,668 339.85
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 24,782,551 32,074,696 339.85
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 1,823,036 1,823,036
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 7,292,145 7,292,145
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22,924,794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11,468,283
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -781,860 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -195,466 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -195,466 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1,781,843 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -593,948 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -593,948 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -5,000,000 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -5,000,000 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -3,830,402 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -15,323,593 0 -100.00
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 781,860 2,563,703 43.88
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 195,466 5,789,414 3.49
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 195,466 5,789,414 3.49
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 1,781,843 1,781,843
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 593,948 5,593,948 11.88
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 593,948 5,593,948 11.88
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 5,000,000 5,000,000
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 5,000,000 5,000,000
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 3,830,402 3,830,402
2018-07-23 2018-07-20 4 RUBY Rubius Therapeutics, Inc.
Common Stock
C - Conversion 15,323,593 15,323,593
2018-07-18 2018-07-17 4 RUBY Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-07-17 3 RUBY Rubius Therapeutics, Inc.
Common Stock
10,000,000
2018-06-27 2018-06-26 4 MCRB Seres Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Series C Preferred Stock
C - Conversion -4,643,963 0 -100.00
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Series B Preferred Stock
C - Conversion -18,611,110 0 -100.00
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Series A-3 Preferred Stock
C - Conversion -8,333,000 0 -100.00
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Series A-2 Preferred Stock
C - Conversion -5,416,667 0 -100.00
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Series A-1 Preferred Stock
C - Conversion -10,102,055 0 -100.00
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Series A Preferred Stock
C - Conversion -12,536,945 0 -100.00
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 281,250 18,233,403 1.57 16.00 4,500,000 291,734,448
2018-05-15 2018-05-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
C - Conversion 14,622,143 17,952,153 439.10
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-05-08 3 EVLO Evelo Biosciences, Inc.
Common Stock
6,660,018
2018-02-13 2017-09-08 5 SYRS Syros Pharmaceuticals, Inc.
Common Stock
G - Gift -24,527 0 -100.00
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Series C Preferred Stock
C - Conversion -352,800 0 -100.00
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Series B Preferred Stock
C - Conversion -1,533,214 0 -100.00
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Series A-2 Preferred Stock
C - Conversion -3,360,000 0 -100.00
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Series A-1 Preferred Stock
C - Conversion -1,280,000 0 -100.00
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Common Stock
C - Conversion 109,770 2,030,495 5.72
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Common Stock
C - Conversion 477,042 1,920,725 33.04
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Common Stock
C - Conversion 1,045,426 1,443,683 262.50
2017-12-13 2017-12-11 4 QTRX Quanterix Corp
Common Stock
C - Conversion 398,257 398,257
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Series B-1 Preferred Stock
C - Conversion -156,250 0 -100.00
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Series A-2 Preferred Stock
C - Conversion -125,000 0 -100.00
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Series A-1 Preferred Stock
C - Conversion -8,324,999 0 -100.00
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Common Stock
C - Conversion 8,606,249 8,918,749 2,754.00
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
625,000
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
625,000
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
625,000
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
625,000
2017-08-21 2017-08-17 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
J - Other -54,293 0 -100.00
2017-08-21 2017-08-17 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
J - Other -306,222 612,442 -33.33
2017-08-21 2017-08-17 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
J - Other -1,295,997 2,378,663 -35.27
2017-06-21 2017-06-20 4 MCRB Seres Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2016-09-26 2016-09-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -10,293 106,787 -8.79 3.10 -31,908 331,040
2016-09-26 2016-09-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -41,178 426,885 -8.80 3.10 -127,652 1,323,344
2016-09-26 2016-09-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -3,118 117,080 -2.59 3.16 -9,853 369,973
2016-09-26 2016-09-23 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -12,482 468,063 -2.60 3.16 -39,443 1,479,079
2016-09-26 2016-09-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -47,090 120,198 -28.15 3.17 -149,275 381,028
2016-09-26 2016-09-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -188,367 480,545 -28.16 3.17 -597,123 1,523,328
2016-09-26 2016-09-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -28,163 167,288 -14.41 3.18 -89,558 531,976
2016-09-26 2016-09-22 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -112,731 668,912 -14.42 3.18 -358,485 2,127,140
2016-09-21 2016-09-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -64,509 195,451 -24.81 3.75 -241,909 732,941
2016-09-21 2016-09-21 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -258,214 781,643 -24.83 3.75 -968,302 2,931,161
2016-09-21 2016-09-20 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -10,778 259,960 -3.98 3.39 -36,537 881,264
2016-09-21 2016-09-20 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -43,139 1,039,857 -3.98 3.39 -146,241 3,525,115
2016-09-21 2016-09-19 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -1,939 270,738 -0.71 3.31 -6,418 896,143
2016-09-21 2016-09-19 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -7,761 1,082,996 -0.71 3.31 -25,689 3,584,717
2016-09-16 2016-09-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -536 272,677 -0.20 4.16 -2,230 1,134,336
2016-09-16 2016-09-15 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -2,145 1,090,757 -0.20 4.16 -8,923 4,537,549
2016-09-16 2016-09-14 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -8,802 273,213 -3.12 4.18 -36,792 1,142,030
2016-09-16 2016-09-14 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -35,209 1,092,902 -3.12 4.18 -147,174 4,568,330
2016-09-08 2016-09-07 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -8,145 282,015 -2.81 4.51 -36,734 1,271,888
2016-09-08 2016-09-07 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -32,597 1,128,111 -2.81 4.51 -147,012 5,087,781
2016-09-08 2016-09-07 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -52,985 1,833,802 -2.81 4.51 -238,962 8,270,447
2016-09-08 2016-09-06 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -3,108 290,160 -1.06 4.63 -14,390 1,343,441
2016-09-08 2016-09-06 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -12,441 1,160,708 -1.06 4.63 -57,602 5,374,078
2016-09-08 2016-09-06 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
S - Sale -20,221 1,886,787 -1.06 4.63 -93,623 8,735,824
2016-08-15 2016-08-11 4 EDIT Editas Medicine, Inc.
Common Stock
J - Other -50,271 0 -100.00
2016-08-15 2016-08-11 4 EDIT Editas Medicine, Inc.
Common Stock
J - Other -300,000 691,060 -30.27
2016-08-15 2016-08-11 4 EDIT Editas Medicine, Inc.
Common Stock
J - Other -1,200,000 2,764,256 -30.27
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -444,995 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -1,779,981 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series A-3 Preferred Stock
C - Conversion -1,500,000 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series A-3 Preferred Stock
C - Conversion -6,000,000 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series A-2 Preferred Stock
C - Conversion -1,000,000 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series A-2 Preferred Stock
C - Conversion -4,000,000 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series A-1 Preferred Stock
C - Conversion -200,000 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Series A-1 Preferred Stock
C - Conversion -800,000 0 -100.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
P - Purchase 80,000 918,664 9.54 12.50 1,000,000 11,483,300
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
P - Purchase 320,000 3,674,660 9.54 12.50 4,000,000 45,933,250
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 118,665 838,664 16.48
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 474,661 3,354,660 16.48
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 400,000 719,999 125.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 1,600,000 2,879,999 125.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 266,666 319,999 500.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 1,066,666 1,279,999 500.00
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 53,333 53,333
2016-07-07 2016-07-06 4 SYRS Syros Pharmaceuticals, Inc.
Common Stock
C - Conversion 213,333 213,333
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock
C - Conversion -125,008 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock
C - Conversion -241,718 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock
C - Conversion -235,042 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series B Convertible Preferred Stock
C - Conversion -631,458 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series A Convertible Preferred Stock
C - Conversion -318,752 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock
C - Conversion 193,777 1,651,862 13.29
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock
C - Conversion 241,718 1,458,085 19.87
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock
C - Conversion 235,042 1,216,367 23.95
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock
C - Conversion 631,458 981,325 180.49
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock
C - Conversion 318,752 349,867 1,024.43
2016-06-29 3 SYRS Syros Pharmaceuticals, Inc.
Common Stock
426,664
2016-06-29 3 SYRS Syros Pharmaceuticals, Inc.
Common Stock
426,664
2016-06-29 3 SYRS Syros Pharmaceuticals, Inc.
Common Stock
426,664
2016-06-29 3 SYRS Syros Pharmaceuticals, Inc.
Common Stock
426,664
2016-06-29 3 SYRS Syros Pharmaceuticals, Inc.
Common Stock
426,664
2016-06-29 3 SYRS Syros Pharmaceuticals, Inc.
Common Stock
426,664
2016-06-29 3 SYRS Syros Pharmaceuticals, Inc.
Common Stock
426,664
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock
62,230
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock
62,230
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock
62,230
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock
62,230
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock
62,230
2016-06-17 2016-06-15 4 MCRB Seres Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
J - Other -33,514 0 -100.00
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
J - Other 7 33,514 0.02
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
J - Other 33,507 33,514 478,671.43
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
J - Other -200,000 1,925,462 -9.41
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
J - Other -800,000 8,022,420 -9.07
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
S - Sale -599,297 0 -100.00 27.60 -16,540,597
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
S - Sale -80,141 1,925,462 -4.00 27.60 -2,211,892 53,142,751
2016-05-27 2016-05-25 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
S - Sale -320,562 2,734,994 -10.49 27.60 -8,847,511 75,485,834
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Series B Preferred Stock
C - Conversion -199,999 0 -100.00
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Series A-2 Preferred Stock
C - Conversion -1,051,060 0 -100.00
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Series A-1 Preferred Stock
C - Conversion -1,325,708 0 -100.00
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Series B Preferred Stock
C - Conversion -800,001 0 -100.00
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Series A-2 Preferred Stock
C - Conversion -4,204,240 0 -100.00
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Series A-1 Preferred Stock
C - Conversion -5,302,834 0 -100.00
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Common Stock
C - Conversion 76,922 991,060 8.41
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Common Stock
C - Conversion 404,253 914,138 79.28
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Common Stock
C - Conversion 509,885 509,885
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Common Stock
C - Conversion 307,692 3,964,256 8.41
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Common Stock
C - Conversion 1,617,015 3,656,564 79.28
2016-02-09 2016-02-08 4 EDIT Editas Medicine, Inc.
Common Stock
C - Conversion 2,039,549 2,039,549
2015-12-11 2015-12-09 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -2,508 0 -100.00 0.56 -1,404
2015-12-11 2015-12-09 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -43,930 0 -100.00 0.56 -24,601
2015-11-20 2015-11-18 4 BGMD BG Medicine, Inc.
Stock Option (right to buy)
A - Award 5,000 5,000
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -508 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -3,256 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -32 58,232 -0.05 2.27 -73 132,187
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 508 58,264 0.88 0.14 71 8,157
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57,756 -0.03 2.27 -36 131,106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57,756 -0.03 2.27 -36 131,106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57,756 -0.03 2.27 -36 131,106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57,756 -0.03 2.27 -36 131,106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57,772 0.44 0.14 36 8,088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57,772 0.44 0.14 36 8,088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57,772 0.44 0.14 36 8,088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57,772 0.44 0.14 36 8,088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -206 56,804 -0.36 2.27 -468 128,945
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 3,256 57,010 6.06 0.14 456 7,981
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -8,410 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4,205 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4,205 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4,205 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4,205 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -53,857 0 -100.00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -530 786,970 -0.07 2.27 -1,203 1,786,422
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 8,410 787,500 1.08 0.14 1,177 110,250
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779,090 -0.03 2.27 -602 1,768,534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779,090 -0.03 2.27 -602 1,768,534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779,090 -0.03 2.27 -602 1,768,534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779,090 -0.03 2.27 -602 1,768,534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4,205 779,355 0.54 0.14 589 109,110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4,205 779,355 0.54 0.14 589 109,110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4,205 779,355 0.54 0.14 589 109,110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4,205 779,355 0.54 0.14 589 109,110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -3,390 763,330 -0.44 2.27 -7,695 1,732,759
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 53,857 766,720 7.56 0.14 7,540 107,341
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
P - Purchase 397,072 497,729 394.48 1.70 675,142 846,289
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
C - Conversion 100,657 100,657
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
C - Conversion
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
C - Conversion
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
J - Other
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
J - Other
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
P - Purchase 53,465 67,018 394.49 1.70 90,907 113,951
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
C - Conversion 13,553 13,553
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
C - Conversion
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
J - Other
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
P - Purchase 725,725 909,696 394.48 1.70 1,233,950 1,546,756
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
C - Conversion 183,971 183,971
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -454,546 0 -100.00
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -1,818,181 0 -100.00
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -224,719 0 -100.00
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -898,877 0 -100.00
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -599,297 0 -100.00
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -1,526,338 0 -100.00
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -6,105,362 0 -100.00
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
C - Conversion 599,297 599,297
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
C - Conversion 2,205,603 2,205,603
2015-06-29 2015-06-26 4 MCRB Seres Therapeutics, Inc.
Common Stock, $0.001 par value
C - Conversion 8,822,420 8,822,420
2015-06-29 2015-06-25 4 MCRB Seres Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2015-06-25 3 MCRB Seres Therapeutics, Inc.
Common Stock
6,111,112
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other 10,029 10,029
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other 164,528 175,718 1,470.31
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -2,484,192 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -17,080 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -17,080 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -17,080 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -616 2,484,192 -0.02 0.46 -283 1,142,728
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -616 2,484,192 -0.02 0.46 -283 1,142,728
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 17,080 2,484,808 0.69 0.02 342 49,696
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 17,080 2,484,808 0.69 0.02 342 49,696
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 17,080 2,484,808 0.69 0.02 342 49,696
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -616 7,298,474 -0.01 0.46 -283 3,357,298
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -98,570 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,729 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,729 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,729 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -850 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -499 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98,570 -0.06 0.46 -29 45,342
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98,570 -0.06 0.46 -29 45,342
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98,570 -0.06 0.46 -29 45,342
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1,729 98,633 1.78 0.02 35 1,973
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1,729 98,633 1.78 0.02 35 1,973
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1,729 98,633 1.78 0.02 35 1,973
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -32 93,572 -0.03 0.46 -15 43,043
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 850 93,604 0.92 0.02 17 1,872
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -39 92,754 -0.04 0.46 -18 42,667
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 499 92,793 0.54 0.04 20 3,712
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -98,352 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,724 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,724 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,724 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -847 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -464 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98,352 -0.06 0.46 -29 45,242
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98,352 -0.06 0.46 -29 45,242
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98,352 -0.06 0.46 -29 45,242
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1,724 98,415 1.78 0.02 34 1,968
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1,724 98,415 1.78 0.02 34 1,968
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1,724 98,415 1.78 0.02 34 1,968
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -31 93,369 -0.03 0.46 -14 42,950
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 847 93,400 0.92 0.02 17 1,868
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -37 92,553 -0.04 0.46 -17 42,574
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 464 92,590 0.50 0.04 19 3,704
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other 11,190 0 -100.00
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -703,655 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12,183 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12,183 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12,183 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -5,988 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12,021 0 -100.00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -440 703,655 -0.06 0.46 -202 323,681
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -440 703,655 -0.06 0.46 -202 323,681
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -440 703,655 -0.06 0.46 -202 323,681
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12,183 704,095 1.76 0.02 244 14,082
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12,183 704,095 1.76 0.02 244 14,082
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12,183 704,095 1.76 0.02 244 14,082
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -216 668,426 -0.03 0.46 -99 307,476
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 5,988 668,642 0.90 0.02 120 13,373
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -927 662,654 -0.14 0.46 -426 304,821
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12,021 663,581 1.84 0.04 481 26,543
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Series E Convertible Preferred Stock
C - Conversion -631,133 0 -100.00
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Series D Convertible Preferred Stock
C - Conversion -629,851 0 -100.00
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Series C Convertible Preferred Stock
C - Conversion -819,493 0 -100.00
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Series B Convertible Preferred Stock
C - Conversion -1,053,201 0 -100.00
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -774,527 0 -100.00
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -128,567 0 -100.00
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Common Stock
C - Conversion 741,755 2,374,571 45.43
2014-08-14 2014-08-12 4 TTOO T2 Biosystems, Inc.
Common Stock
C - Conversion 1,632,816 1,632,816
2014-06-25 2014-06-23 4 AGIO AGIOS PHARMACEUTICALS INC
Common Stock
J - Other -1,930,369 1,930,369 -50.00
2014-06-05 2014-06-03 4 BGMD BG Medicine, Inc.
Stock Option (right to buy)
A - Award 4,205 4,205
2014-03-24 2014-03-20 4 EBIO Eleven Biotherapeutics, Inc.
Stock Option
A - Award 16,143 16,143
2014-02-19 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -525,500 0 -100.00
2014-02-19 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -3,000,000 0 -100.00
2014-02-19 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 93,008 656,490 16.51
2014-02-19 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 530,974 563,482 1,633.36
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -420,053 0 -100.00
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -1,680,213 0 -100.00
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -1,050,000 0 -100.00
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -4,200,000 0 -100.00
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -9,000,000 0 -100.00
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
P - Purchase 32,912 293,268 12.64 10.00 329,120 2,932,680
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
P - Purchase 131,722 1,173,149 12.65 10.00 1,317,220 11,731,490
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
P - Purchase 214,095 1,907,008 12.65 10.00 2,140,950 19,070,080
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
C - Conversion 231,504 260,356 802.38
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
C - Conversion 926,017 1,041,427 802.37
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock
C - Conversion 1,417,323 1,692,913 514.29
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
65,016
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
65,016
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
65,016
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
65,016
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
65,016
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
695,442
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
535,262
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
448,704
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
695,442
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
535,262
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
448,704
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
695,442
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
535,262
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
448,704
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
695,442
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
535,262
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
448,704
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
695,442
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
535,262
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
448,704
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
695,442
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
535,262
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
448,704
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
695,442
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
535,262
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
448,704
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
275,590
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
115,410
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
Common Stock
28,852
2014-02-05 3 EBIO Eleven Biotherapeutics, Inc.
No securities are beneficially owned
0
2013-11-18 2013-11-18 4 RCPT Receptos, Inc.
Common Stock
S - Sale -20,300 1,693,551 -1.18 24.09 -489,027 40,797,644
2013-11-18 2013-11-15 4 RCPT Receptos, Inc.
Common Stock
S - Sale -904 1,713,851 -0.05 25.10 -22,690 43,017,660
2013-11-18 2013-11-15 4 RCPT Receptos, Inc.
Common Stock
S - Sale -54,000 1,714,755 -3.05 24.20 -1,306,800 41,497,071
2013-11-18 2013-11-14 4 RCPT Receptos, Inc.
Common Stock
S - Sale -155,583 1,768,755 -8.09 25.03 -3,894,242 44,271,938
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Series D Preferred Stock
C - Conversion -407,060 0 -100.00
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Series C-1 Preferred Stock
C - Conversion -333,288 0 -100.00
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Series C Preferred Stock
C - Conversion -416,667 0 -100.00
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Series B Preferred Stock
C - Conversion -1,900,000 0 -100.00
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Series A Preferred Stock
C - Conversion -984,640 0 -100.00
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Common Stock
P - Purchase 20,000 1,562,616 1.30 15.00 300,000 23,439,240
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Common Stock
C - Conversion 1,542,616 1,542,616
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
4,867
2013-07-31 2013-07-29 4 AGIO AGIOS PHARMACEUTICALS INC
Series C-2 Convertible Preferred Stock
C - Conversion -617,031 0 -100.00
2013-07-31 2013-07-29 4 AGIO AGIOS PHARMACEUTICALS INC
Series A Convertible Preferred Stock
C - Conversion -10,000,000 0 -100.00
2013-07-31 2013-07-29 4 AGIO AGIOS PHARMACEUTICALS INC
Common Stock
C - Conversion 3,860,738 3,860,738
2013-06-14 2013-06-12 4 BGMD BG Medicine, Inc.
Stock Option (right to buy)
A - Award 4,205 4,205
2013-05-14 2013-05-14 4 RCPT Receptos, Inc.
Series B Preferred Stock
C - Conversion -4,131,552 0 -100.00
2013-05-14 2013-05-14 4 RCPT Receptos, Inc.
Series A Preferred Stock
C - Conversion -8,640,289 0 -100.00
2013-05-14 2013-05-14 4 RCPT Receptos, Inc.
Common Stock
P - Purchase 107,142 1,924,339 5.90 14.00 1,499,988 26,940,746
2013-05-14 2013-05-14 4 RCPT Receptos, Inc.
Common Stock
C - Conversion 550,873 1,817,197 43.50 7.73 4,258,248 14,046,933
2013-05-14 2013-05-14 4 RCPT Receptos, Inc.
Common Stock
C - Conversion 1,152,039 1,266,324 1,008.04 5.25 6,048,205 6,648,201
2013-05-08 3 RCPT Receptos, Inc.
Common Stock
114,285
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Series C Convertible Participating Preferred Stock
C - Conversion -19,544,924 0 -100.00
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Series C Convertible Participating Preferred Stock
C - Conversion -9,626,604 0 -100.00
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Series B Convertible Participating Preferred Stock
C - Conversion -11,422,045 0 -100.00
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Series A-2 Convertible Participating Preferred Stock
C - Conversion -2,726,088 0 -100.00
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Series A-1 Convertible Participating Preferred Stock
C - Conversion -2,090,000 0 -100.00
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Common Stock
P - Purchase 491,824 1,165,786 72.98 7.00 3,442,768 8,160,502
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Common Stock
C - Conversion 673,962 673,962
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Common Stock
C - Conversion 331,953 891,887 59.28
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Common Stock
C - Conversion 393,863 559,934 237.17
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Common Stock
C - Conversion 94,003 166,071 130.44
2013-03-27 2013-03-25 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Common Stock
C - Conversion 72,068 72,068
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 1,050,000 1,764,286 147.00 2.00 2,100,000 3,528,572
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 500,000 2,851,447 21.26 2.00 1,000,000 5,702,894
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 75,000 215,013 53.57 2.00 150,000 430,026
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 125,000 651,560 23.74 2.00 250,000 1,303,120
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 250,000 2,434,800 11.44 2.00 500,000 4,869,600
2012-08-22 2012-08-21 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -298,137 0 -100.00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -6,422 0 -100.00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -6,422 0 -100.00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -6,422 0 -100.00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -2,353 0 -100.00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -23 298,137 -0.01 5.83 -134 1,738,139
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -23 298,137 -0.01 5.83 -134 1,738,139
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 6,422 298,160 2.20 0.02 128 5,963
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 6,422 298,160 2.20 0.02 128 5,963
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -23 285,339 -0.01 5.83 -134 1,663,526
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 6,422 285,362 2.30 0.02 128 5,707
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -13 278,940 0.00 5.83 -76 1,626,220
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 2,353 278,953 0.85 0.03 71 8,369
2012-06-13 2012-06-11 4 BGMD BG Medicine, Inc.
Stock Option (right to buy)
A - Award 4,205 4,205
2012-05-23 2012-05-23 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -130,867 0 -100.00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -7,001 0 -100.00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -7,001 0 -100.00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -7,001 0 -100.00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -2,580 0 -100.00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -2,497 0 -100.00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -36 130,867 -0.03 3.95 -142 516,925
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -36 130,867 -0.03 3.95 -142 516,925
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -36 130,867 -0.03 3.95 -142 516,925
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 7,001 130,903 5.65 0.02 140 2,618
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 7,001 130,903 5.65 0.02 140 2,618
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 7,001 130,903 5.65 0.02 140 2,618
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -14 109,972 -0.01 3.95 -55 434,389
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 2,580 109,986 2.40 0.02 52 2,200
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -19 107,406 -0.02 3.95 -75 424,254
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 2,497 107,425 2.38 0.03 75 3,223
2012-02-29 2012-02-27 4 BGMD BG Medicine, Inc.
Stock Option (right to buy)
A - Award 4,205 4,205
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)